Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by SouthernTierTomon Apr 21, 2021 10:57am

206 Views

Post# 33036829

Is being valued at 5% of the phase 1 ACID firm good?

It really depends on which side of the tracks you work...

Retail money..from 75 cents CAD before the cancer project even started..not so gouda ; - (

The 30 cent financing with 35 cent warrants and 12.7M options to management at 25 cents ; - )

Cie....it's all about "angles" ...is it an acute tale or one that is obtise and really hard to hold?

I like the story and LOVE management, I feel badly for them that a bullboard program has attached itself to the story like a lampray on a healthy Chinook

Bon chance,
Thome

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China